In order to investigate whether TSPYL5’s impacts on NB malignant progression are dependent on p53 activity, we reduced the p53 expression in the TSPYL5-knockdown NB cells using the TP53-targeted SiRNA (Supplementary Fig. 5a, b). The gene discussed is TP53; the disease is neuroblastoma.